Evidence map›Paper›PMID 24023617›Full record

ArticlePloS one2013

RAG-1 and Ly6D independently reflect progression in the B lymphoid lineage.

Qingzhao Zhang, Brandt L Esplin, Ryuji Iida, Karla P Garrett, Zhixin L Huang, Kay L Medina, Paul W Kincade

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Qingzhao ZhangImmunobiology & Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
Brandt L Esplin
Ryuji Iida
Karla P Garrett
Zhixin L Huang
Kay L Medina
Paul W Kincade
Oklahoma Medical Research Foundation · USMayo Clinic · US

Funding

EARLY EVENTS IN MAMMALIAN B-CELL DIFFERENTIATION.R01AI020069 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KINCADE, PAUL WAYNE · 1985 to 2012
$5.2M
Molecular Events Initiating B Cell Fate DeterminationR01HL096108 · NHLBI · MAYO CLINIC ROCHESTER · PI MEDINA, KAY LYNN · 2009 to 2013
$1.9M
Chronic Toll-like Receptor Ligation and Hematopoietic Stem Cell AgingF30AG031646 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ESPLIN, BRANDT L · 2008 to 2010
$87k
EARLY EVENTS IN MAMMALIAN B-CELL DIFFERENTIATIONR37AI020069 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KINCADE, PAUL WAYNE · 1989 to 1996
–
NHLBI NIH HHS R01 HL096108NHLBI NIH HHS R01HL096108NIAID NIH HHS AI020069NIAID NIH HHS R01 AI020069NIA NIH HHS F30 AG031646NIA NIH HHS F30AG031646
6 · The paper itself

Abstract

Common lymphoid progenitors (CLPs) are thought to represent major intermediates in the transition of hematopoietic stem cells (HSCs) to B lineage lymphocytes. However, it has been obvious for some time that CLPs are heterogeneous, and there has been controversy concerning their differentiation potential. We have now resolved four Flt3(+) CLP subsets that are relatively homogenous and capable of forming B cells. Differentiation potential and gene expression patterns suggest Flt3(+) CLPs lacking both Ly6D and RAG-1 are the least differentiated. In addition to B cells, they generate natural killer (NK) and dendritic cells (DCs). At the other extreme is a subset of the recently described Flt3(+) Ly6D(+) CLPs that have a history of RAG-1 expression and are B lineage restricted. These relatively abundant and potent CLPs were depleted within 48 hours of acute in vivo estrogen elevation, suggesting they descend from hormone regulated progenitors. This contrasts with the hormone insensitivity of other CLP subsets that include NK lineage progenitors. This progenitor heterogeneity and differentiation complexity may add flexibility in response to environmental changes. Expression of RAG-1 and display of Ly6D are both milestone events, but they are neither synchronized nor dependent on each other.

Indexed as

AnimalsAntigens, LyCell DifferentiationCell LineageEstrogensGPI-Linked ProteinsHomeodomain ProteinsLymphocyte CountLymphocyte SubsetsLymphopoiesisMiceMice, Inbred C57BLPrecursor Cells, B-LymphoidSteroidsAntigens, LyEstrogensGPI-Linked ProteinsHomeodomain ProteinsLy6d protein, mouseRAG-1 proteinSteroids

Identifiers

PMID24023617
PMCPMC3758291
OpenAlexW2045320256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.